Neuphoria Therapeutics
(NASDAQ) NEUP
Neuphoria Therapeutics Financials at a Glance
Market Cap
$8.27M
Revenue (TTM)
$8.21M
Net Income (TTM)
$373.34M
EPS (TTM)
$-23.89
P/E Ratio
-0.18
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$4.44
Volume
0
Open
$4.40
Price
$4.44
Volume
0
Open
$4.40
Previous Close
$4.44
Daily Range
$4.38 - $4.44
52-Week Range
$3.65 - $21.40
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$4.44
Volume
0
Open
$4.40
Previous Close
$4.44
Daily Range
$4.38 - $4.44
52-Week Range
$3.65 - $21.40
NEUP News
NEUP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Neuphoria Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
Spyridon Papapetropoulos, MD, PhD
Website
www.neuphoriatx.comHeadquarters
Burlington, US
NEUP Financials
Key Financial Metrics (TTM)
Gross Margin
95%
Operating Margin
-137%
Net Income Margin
-45%
Return on Equity
0%
Return on Capital
-33%
Return on Assets
-10%
Earnings Yield
-5.56%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.27M
Shares Outstanding
1.88M
Volume
0
Short Interest
0.00%
Avg. Volume
47.69K
Financials (TTM)
Gross Profit
$22.94M
Operating Income
$1.73M
EBITDA
$268.02K
Operating Cash Flow
$77.23M
Capital Expenditure
$0.00
Free Cash Flow
$77.23M
Cash & ST Invst.
$21.59M
Total Debt
$226.49K
Neuphoria Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$248.37K
N/A
Gross Margin
0.00%
N/A
Market Cap
$8.27M
N/A
Market Cap/Employee
$1.03M
N/A
Employees
8
N/A
Net Income
$1.86M
+159.4%
EBITDA
$3.98M
-27.6%
Quarterly Fundamentals
Net Cash
$22.12M
+433.6%
Accounts Receivable
$1.66M
+4575.8%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$50.13K
-66.5%
Return on Assets
-10.20%
N/A
Return on Invested Capital
-33.15%
N/A
Free Cash Flow
$6.44M
-91.7%
Operating Cash Flow
$6.44M
-91.7%